A study today in Infection Control & Hospital Epidemiology has determined that an electronic best practice advisory combined with prescriber education was associated with reduced antibiotic prescribing for adults with acute bronchitis.
An analysis of almost 160,000 pneumonia patients in 170 US hospitals indicates that urinary antigen testing (UAT), a practice recommended by national guidelines to allow for antibiotic de-escalation in patients with community-acquired pneumonia (CAP), is not widely performed, researchers reported today in Clinical Infectious Diseases.
Accelerate Diagnostics presented three studies today at IDWeek 2019 in Washington, DC, that show promising results for its rapid phenotypic susceptibility test, according to a company press release.
Use of a rapid molecular identification test on positive blood cultures from critically ill patients with bloodstream infections was associated with significantly reduced time to optimal antibiotic treatment, Belgian researchers reported yesterday in PLOS One.
The US Centers for Disease Control and Prevention (CDC) announced yesterday that the Pan American Health Organization (PAHO)/World Health Organization (WHO) have designated the CDC's Center for Global Health as a PAHO/WHO Collaborating Center for Biosafety and Biosecurity.
US and Canadian researchers, writing in the Annals of Internal Medicine today, said they have determined that, among patients with severe manifestations of sepsis, initiation of empirical antimicrobial therapy significantly reduces the sensitivity of blood cultures drawn shortly after treatment began—underscoring the need for early diagnostic blood tests.
A study by Italian investigators in Clinical Microbiology and Infection has found that commercial methods for testing carbapenem susceptibility produced widely variable results in a sample of carbapenemase-producing Escherichia coli, with none satisfying the criteria for acceptable antimicrobial susceptibility testing (AST) performance.
CARB-X today announced funding for the development of an alternative treatment for infections caused by a multidrug-resistant strain of Escherichia coli.
A cost-effectiveness analysis indicates a Staphylococcus aureus decolonization protocol for patients undergoing hip and knee replacement could result in cost savings and fewer surgical-site infections (SSIs), Canadian researchers reported yesterday in Antimicrobial Resistance and Infection Control.
Antibiotic prescribing guided by C-reactive protein testing resulted in a lower rate of those drugs for COPD exacerbations in Britain.
